Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

Myosin-XIX Inhibitors

Myosin-XIX inhibitors represent a specialized category of chemical agents designed to modulate the activity of Myosin-XIX, a class of unconventional myosin proteins. Myosin proteins are molecular motors that interact with actin filaments to facilitate intracellular transport, cellular movement, and other critical cytoskeletal dynamics. Myosin-XIX, in particular, is distinguished by its unique motor domain and its ability to navigate actin networks in ways that differ from conventional myosins. The regulation of Myosin-XIX activity is critical for understanding cellular processes such as organelle positioning, membrane trafficking, and mechanical force generation. Inhibitors of Myosin-XIX typically target the motor domain or the associated regulatory regions, preventing the hydrolysis of ATP that powers the myosin motor. By modulating ATPase activity or disrupting actin binding, these inhibitors can prevent Myosin-XIX from executing its mechanical functions, ultimately impacting the dynamics of actin filaments and cytoskeletal integrity.

Chemically, Myosin-XIX inhibitors are diverse and can be classified based on their binding mechanisms or molecular interactions with the myosin protein. Some inhibitors may function by occupying ATP binding pockets, thereby preventing ATP hydrolysis, while others may alter the myosin-actin interaction by binding to allosteric sites on the myosin molecule. These inhibitors often exhibit high specificity for Myosin-XIX over other myosin isoforms, which is a critical factor for studying the precise role of Myosin-XIX in various cellular contexts. In research settings, the application of these inhibitors can help scientists dissect the exact functions of Myosin-XIX in complex cellular pathways, including its role in cytoskeletal organization, cell polarity, and intracellular cargo transport. Studying the chemical interactions and inhibitory mechanisms provides valuable insights into the biochemical principles that govern motor protein regulation and the broader landscape of molecular motors in cell biology.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Geldanamycin

30562-34-6sc-200617B
sc-200617C
sc-200617
sc-200617A
100 µg
500 µg
1 mg
5 mg
$39.00
$59.00
$104.00
$206.00
8
(1)

HSP90 inhibitor that can destabilize client proteins, potentially affecting KRTAP9-3 stability.

Withaferin A

5119-48-2sc-200381
sc-200381A
sc-200381B
sc-200381C
1 mg
10 mg
100 mg
1 g
$130.00
$583.00
$4172.00
$20506.00
20
(1)

Compound known to disrupt cytoskeletal proteins, which could affect KRTAP9-3's interaction with keratins.

Cycloheximide

66-81-9sc-3508B
sc-3508
sc-3508A
100 mg
1 g
5 g
$41.00
$84.00
$275.00
127
(6)

Protein synthesis inhibitor that can reduce overall protein levels, potentially reducing KRTAP9-3 expression.

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$60.00
$265.00
$1000.00
163
(3)

Proteasome inhibitor that can increase protein levels, potentially affecting KRTAP9-3 turnover.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

Histone deacetylase inhibitor that can alter gene expression, potentially affecting KRTAP9-3 expression.

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

DNA methyltransferase inhibitor that can affect gene expression, potentially influencing KRTAP9-3.

Alsterpaullone

237430-03-4sc-202453
sc-202453A
1 mg
5 mg
$68.00
$312.00
2
(1)

Cyclin-dependent kinase inhibitor that can disrupt cell cycle, potentially affecting KRTAP9-3 levels.

Thapsigargin

67526-95-8sc-24017
sc-24017A
1 mg
5 mg
$136.00
$446.00
114
(2)

SERCA pump inhibitor that can induce ER stress, potentially impacting KRTAP9-3 folding or stability.

Retinoic Acid, all trans

302-79-4sc-200898
sc-200898A
sc-200898B
sc-200898C
500 mg
5 g
10 g
100 g
$66.00
$325.00
$587.00
$1018.00
28
(1)

Signaling molecule that can regulate gene expression, potentially affecting KRTAP9-3 levels.

Chloroquine

54-05-7sc-507304
250 mg
$69.00
2
(0)

Lysosomotropic agent that can raise lysosomal pH, potentially affecting KRTAP9-3 degradation.